REPORT ID 1846

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market ResearchReport 2019

Publish Date
2019
Pages
129
Format
Electronic (PDF)

In this report, the global Chemotherapy Induced Peripheral Neuropathy Treatment market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Chemotherapy Induced Peripheral Neuropathy Treatment in these regions, from   2019 to 2025 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Chemotherapy Induced Peripheral Neuropathy Treatment market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Achelios Therapeutics Inc
    Advinus Therapeutics Ltd
    Apollo Endosurgery Inc
    Aptinyx Inc
    Asahi Kasei Pharma Corp
    Can-Fite BioPharma Ltd
    Celgene Corp
    DermaXon LLC
    Eisai
    Immune Pharmaceuticals Inc
    INSYS Therapeutics Inc
    Kineta Inc
    KPI Therapeutics Inc
    Krenitsky Pharmaceuticals Inc
    MAKScientific LLC
    Metys Pharmaceuticals AG
    Midatech Pharma US Inc
    Mundipharma International Ltd
    Nemus Bioscience Inc
    Neurocentrx Pharma Ltd
    Panacea Pharmaceuticals Inc
    PeriphaGen Inc
    PharmatrophiX Inc
    PledPharma AB
    Sova Pharmaceuticals Inc
    Virobay Inc
    WEX Pharmaceuticals Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    APX-3330
    BR-297
    Cannabidiol
    Dimiracetam
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Clinic
    Hospital
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Research  Report 2019
1 Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview
    1.1 Product Overview and Scope of Chemotherapy Induced Peripheral Neuropathy Treatment
    1.2 Chemotherapy Induced Peripheral Neuropathy Treatment Segment by Type (Product Category)
        1.2.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Production and CAGR (%) Comparison by Type (Product Category)( 2014-2024)
        1.2.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Production Market Share by Type (Product Category)  in 2018
        1.2.3 APX-3330
        1.2.4 BR-297
        1.2.5 Cannabidiol
        1.2.6 Dimiracetam
        1.2.7 Others
    1.3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Segment by Application
        1.3.1 Chemotherapy Induced Peripheral Neuropathy Treatment Consumption (Sales) Comparison by Application ( 2014-2024)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market by Region ( 2014-2024)
        1.4.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size (Value) and CAGR (%) Comparison by Region ( 2014-2024)
        1.4.2 North America Status and Prospect ( 2014-2024)
        1.4.3 Europe Status and Prospect ( 2014-2024)
        1.4.4 China Status and Prospect ( 2014-2024)
        1.4.5 Japan Status and Prospect ( 2014-2024)
        1.4.6 Southeast Asia Status and Prospect ( 2014-2024)
        1.4.7 India Status and Prospect ( 2014-2024)
    1.5 Global Market Size (Value) of Chemotherapy Induced Peripheral Neuropathy Treatment ( 2014-2024)
        1.5.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Status and Outlook ( 2014-2024)
        1.5.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production Status and Outlook ( 2014-2024)

2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Competition by Manufacturers
    2.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production and Share by Manufacturers ( 2014-2019)
        2.1.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Capacity and Share by Manufacturers ( 2014-2019)
        2.1.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Production and Share by Manufacturers ( 2014-2019)
    2.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Share by Manufacturers ( 2014-2019)
    2.3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Average Price by Manufacturers ( 2014-2019)
    2.4 Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Chemotherapy Induced Peripheral Neuropathy Treatment Market Competitive Situation and Trends
        2.5.1 Chemotherapy Induced Peripheral Neuropathy Treatment Market Concentration Rate
        2.5.2 Chemotherapy Induced Peripheral Neuropathy Treatment Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue (Value) by Region ( 2014-2019)
    3.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Capacity and Market Share by Region ( 2014-2019)
    3.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Production and Market Share by Region ( 2014-2019)
    3.3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue (Value) and Market Share by Region ( 2014-2019)
    3.4 Global Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.5 North America Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.6 Europe Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.7 China Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.8 Japan Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.9 Southeast Asia Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.10 India Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)

4 Global Chemotherapy Induced Peripheral Neuropathy Treatment Supply (Production), Consumption, Export, Import by Region ( 2014-2019)
    4.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Consumption by Region ( 2014-2019)
    4.2 North America Chemotherapy Induced Peripheral Neuropathy Treatment Production, Consumption, Export, Import ( 2014-2019)
    4.3 Europe Chemotherapy Induced Peripheral Neuropathy Treatment Production, Consumption, Export, Import ( 2014-2019)
    4.4 China Chemotherapy Induced Peripheral Neuropathy Treatment Production, Consumption, Export, Import ( 2014-2019)
    4.5 Japan Chemotherapy Induced Peripheral Neuropathy Treatment Production, Consumption, Export, Import ( 2014-2019)
    4.6 Southeast Asia Chemotherapy Induced Peripheral Neuropathy Treatment Production, Consumption, Export, Import ( 2014-2019)
    4.7 India Chemotherapy Induced Peripheral Neuropathy Treatment Production, Consumption, Export, Import ( 2014-2019)

5 Global Chemotherapy Induced Peripheral Neuropathy Treatment Production, Revenue (Value), Price Trend by Type
    5.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Production and Market Share by Type ( 2014-2019)
    5.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Market Share by Type ( 2014-2019)
    5.3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Price by Type ( 2014-2019)
    5.4 Global Chemotherapy Induced Peripheral Neuropathy Treatment Production Growth by Type ( 2014-2019)

6 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Analysis by Application
    6.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Consumption and Market Share by Application ( 2014-2019)
    6.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Consumption Growth Rate by Application ( 2014-2019)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Chemotherapy Induced Peripheral Neuropathy Treatment Manufacturers Profiles/Analysis
    7.1 Achelios Therapeutics Inc
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Achelios Therapeutics Inc Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.1.4 Main Business/Business Overview
    7.2 Advinus Therapeutics Ltd
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Advinus Therapeutics Ltd Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.2.4 Main Business/Business Overview
    7.3 Apollo Endosurgery Inc
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Apollo Endosurgery Inc Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.3.4 Main Business/Business Overview
    7.4 Aptinyx Inc
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Aptinyx Inc Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.4.4 Main Business/Business Overview
    7.5 Asahi Kasei Pharma Corp
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Asahi Kasei Pharma Corp Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.5.4 Main Business/Business Overview
    7.6 Can-Fite BioPharma Ltd
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Can-Fite BioPharma Ltd Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.6.4 Main Business/Business Overview
    7.7 Celgene Corp
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Celgene Corp Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.7.4 Main Business/Business Overview
    7.8 DermaXon LLC
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 DermaXon LLC Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.8.4 Main Business/Business Overview
    7.9 Eisai
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Eisai Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.9.4 Main Business/Business Overview
    7.10 Immune Pharmaceuticals Inc
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Immune Pharmaceuticals Inc Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.10.4 Main Business/Business Overview
    7.11 INSYS Therapeutics Inc
    7.12 Kineta Inc
    7.13 KPI Therapeutics Inc
    7.14 Krenitsky Pharmaceuticals Inc
    7.15 MAKScientific LLC
    7.16 Metys Pharmaceuticals AG
    7.17 Midatech Pharma US Inc
    7.18 Mundipharma International Ltd
    7.19 Nemus Bioscience Inc
    7.20 Neurocentrx Pharma Ltd
    7.21 Panacea Pharmaceuticals Inc
    7.22 PeriphaGen Inc
    7.23 PharmatrophiX Inc
    7.24 PledPharma AB
    7.25 Sova Pharmaceuticals Inc
    7.26 Virobay Inc
    7.27 WEX Pharmaceuticals Inc

8 Chemotherapy Induced Peripheral Neuropathy Treatment Manufacturing Cost Analysis
    8.1 Chemotherapy Induced Peripheral Neuropathy Treatment Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Chemotherapy Induced Peripheral Neuropathy Treatment

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Chemotherapy Induced Peripheral Neuropathy Treatment Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Chemotherapy Induced Peripheral Neuropathy Treatment Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast ( 2019-2025)
    12.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Revenue Forecast ( 2019-2025)
        12.1.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production and Growth Rate Forecast ( 2019-2025)
        12.1.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Growth Rate Forecast ( 2019-2025)
        12.1.3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Price and Trend Forecast ( 2019-2025)
    12.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Production, Consumption , Import and Export Forecast by Region ( 2019-2025)
        12.2.1 North America Chemotherapy Induced Peripheral Neuropathy Treatment Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.2 Europe Chemotherapy Induced Peripheral Neuropathy Treatment Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.3 China Chemotherapy Induced Peripheral Neuropathy Treatment Production, Revenue, Consumption